Your browser doesn't support javascript.
loading
PTEN Loss and BRCA1 Promoter Hypermethylation Negatively Predict for Immunogenicity in BRCA-Deficient Ovarian Cancer.
Kraya, Adam A; Maxwell, Kara N; Eiva, Monika A; Wubbenhorst, Bradley; Pluta, John; Feldman, Michael; Nayak, Anupma; Powell, Daniel J; Domchek, Susan M; Vonderheide, Robert H; Nathanson, Katherine L.
Affiliation
  • Kraya AA; Division of Translational Medicine and Human Genetics, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
  • Maxwell KN; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
  • Eiva MA; Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
  • Wubbenhorst B; Division of Translational Medicine and Human Genetics, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
  • Pluta J; Division of Translational Medicine and Human Genetics, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
  • Feldman M; Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
  • Nayak A; Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
  • Powell DJ; Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
  • Domchek SM; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
  • Vonderheide RH; Basser Center for BRCA and Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
  • Nathanson KL; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
JCO Precis Oncol ; 6: e2100159, 2022 02.
Article in En | MEDLINE | ID: mdl-35201851
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Germ-Line Mutation Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: JCO Precis Oncol Year: 2022 Document type: Article Affiliation country: Panama
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Germ-Line Mutation Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: JCO Precis Oncol Year: 2022 Document type: Article Affiliation country: Panama